Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation and its executives, accusing them of misleading investors by inflating sales figures through an undisclosed discount program that caused excess inventory and overstated revenue. The lawsuit covers stock purchases between February 2024 and February 2026, highlighting significant declines in handpiece sales and missed revenue guidance announced in 2025 and early 2026, which led to sharp stock price drops. Investors who suffered losses during this period have until September 22, 2026, to seek lead plaintiff status in the case. The lawsuit alleges violations of securities laws due to false and misleading statements about the company’s financial health and sales performance.
Baker Hughes Company is set to report its Q2 2026 earnings with analysts forecasting EPS between $0.49 and $0.51 and revenue around $6.49 to $6.51 billion, both reflecting a year-over-year decline. Despite this, the company has a solid track record o...
Stocks of several companies jumped significantly today due to key corporate developments. STAK Inc. led with a 596% rise after announcing a U.S. subsidiary to develop power systems for AI data centers, highlighting investor interest in AI infrastruct...
Faraday Future Intelligent Electric Inc. saw its stock drop nearly 40% despite recent product showcases, indicating investor worries beyond its new offerings. Zevra Therapeutics' shares fell almost 24% after the European Medicines Agency issued a neg...
NovaBridge Biosciences announced its annual general meeting (AGM) will be held on September 8, 2026, in Shanghai. The company is advancing clinical-stage biopharmaceutical treatments, including givastomig for gastric cancer and VIS-101 for retinal di...
Pelthos Therapeutics announced its 2026 Annual Meeting of Stockholders will be held virtually on September 29, 2026, at 9:00 a.m. Eastern Time. Stockholders of record as of August 4, 2026, are eligible to vote. The company will file the official noti...
